Patrick G. Enright Sells 600,000 Shares https://www.chaffeybreeze.com/2017/03/15/patrick-g-enright-sells-600000-shares-of-corcept-therapeutics-incorporated-cort-stock.html
Director Patrick G. Enright sold 600,000 shares of the firm’s stock in a transaction dated Wednesday, March 15th. The stock was sold at an average price of $10.15, for a total value of $6,090,000.00. Following the completion of the transaction, the director now owns 204,210 shares of the company’s stock, valued at $2,072,731.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through
this hyperlink.
Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) traded up 2.82% on Wednesday, hitting $10.21. The stock had a trading volume of 1,170,543 shares. Corcept Therapeutics Incorporated has a 52-week low of $3.85 and a 52-week high of $11.40. The firm has a market cap of $1.15 billion, a PE ratio of 145.86 and a beta of 1.72. The firm’s 50-day moving average price is $8.55 and its 200 day moving average price is $7.67.
Corcept Therapeutics (NASDAQ:CORT) last posted its quarterly earnings results on Monday, March 6th. The company reported $0.04 EPS for the quarter, meeting the consensus estimate of $0.04. Corcept Therapeutics had a net margin of 6.21% and a return on equity of 28.11%. On average, equities research analysts predict that Corcept Therapeutics Incorporated will post $0.26 EPS for the current year.